A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Completed · Phase 2 · Has a placebo group

Conditions studied: Essential Tremor

In brief

This study will look at the ability of ST101 to treat symptoms in subjects with Essential Tremor. This study will also examine the safety and tolerability of the drug. This study is evaluating one dose level of ST101 versus placebo in a cross-over fashion. This means that all patients will receive both ST101 and placebo, but they will receive it in a random (by chance) order.

Key facts

Study ID
NCT01332695
Run by
Sonexa Therapeutics, Inc.
People needed
25
Starts
2011-04-01
Expected to finish
2011-12-01
Last updated by the study team
2012-01-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.